<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1809</article-id><article-id pub-id-type="doi">10.32687/1561-5936-2025-29-3-227-230</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Improvement of production of standard isohemagglutinizing serum ABO kits from the point of import substitution and reduction of financial costs</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Тураева</surname><given-names>Роза Рамильевна</given-names></name><bio></bio><email>turaeva_roza@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Тураев</surname><given-names>Рамиль Габдельхакович</given-names></name><bio></bio><email>ramil.turaev@tatar.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Хакимова</surname><given-names>Рамзия Ильгизовна</given-names></name><bio></bio><email>dls.rck@tatar.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Зарипова</surname><given-names>Регина Маратовна</given-names></name><bio></bio><email>dls.rck@tatar.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Мингазова</surname><given-names>Эльмира Нурисламовна</given-names></name><bio></bio><email>elmira_mingazova@mail.ru</email><xref ref-type="aff" rid="aff-3"/><xref ref-type="aff" rid="aff-4"/><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Жибурт</surname><given-names>Евгений Борисович</given-names></name><bio></bio><email>006</email><xref ref-type="aff" rid="aff-6"/></contrib></contrib-group><aff id="aff-1">Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan, Kazan, Russia</aff><aff id="aff-2">Republican Blood Center of the Ministry of Health of the Republic of Tatarstan, Kazan, Russia</aff><aff id="aff-3">N. A. Semashko National Research Institute of Public Health, Moscow, Russia</aff><aff id="aff-4">Russian Medical Academy of Continuous Professional Education, Moscow, Russia</aff><aff id="aff-5">Kazan State Medical University, Kazan, Russia</aff><aff id="aff-6">Pirogov National Medical and Surgical Center, Ministry of Health of Russia, Moscow, Russia</aff><pub-date date-type="epub" iso-8601-date="2025-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2025</year></pub-date><issue>3</issue><fpage>227</fpage><lpage>230</lpage><history><pub-date date-type="received" iso-8601-date="2025-10-17"><day>17</day><month>10</month><year>2025</year></pub-date></history><permissions><copyright-statement>Copyright © 2025,</copyright-statement><copyright-year>2025</copyright-year></permissions><abstract>The aim of this study was to prepare proposals to improve the production of standard ABO isohemagglutinin serum kits based on an assessment of the phenotypic, temporal, and gender characteristics of the prevalence of high-titer regular antibodies of the ABO system. Materials and methods. In 2021—2023, the Republican Blood Center of the Ministry of Health of the Republic of Tatarstan conducted a study of the titer of natural group antibodies in blood samples of all donors, except for group AB, in order to detect high (1:256 and higher) titers necessary for the production of standard ABO isohemagglutinin serum. A total of 38,795 donors were examined, high-titer regular antibodies of the ABO system were detected in 58 (15.0 ‰O). The phenotypic, temporal, and gender characteristics of the occurrence of high-titer regular antibodies of the ABO system were assessed. Results. The proportion of women among donors was 29.8%. Over the entire observation period, high-titer regular antibodies of the ABO system were found in women by 19.3 ‰O more often than in men (plt;0.001). The frequency of occurrence of high-titer regular antibodies of the ABO system has no gender differences in the O and A phenotypes and is significantly higher in female donors of the B phenotype by 51.0 ‰O (plt;0.001). Anti-B are less common than anti-A by 11.8 ‰O (plt;0.03). Conclusion. The revealed increased frequency of anti-A in female donors of the Republic of Tatarstan allows us to recommend examining no more than 50% of female donors for high-titer regular antibodies and completely abandoning the search for these antibodies in men of group B. Based on the experience of 2021—2023 such a reduction would amount to 8662 out of 38795 studies or a reduction in material and labor costs by 22.3%.</abstract><kwd-group xml:lang="en"><kwd>ABO blood group system, donors, blood components, immunohematology, antibodies, immune antibodies</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>система группы крови АВО, доноры, компоненты крови, иммуногематология, антитела, иммунные антитела</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Zhiburt E. B., Chemodanov I. G., Averyanov E. G., Kozhemyako O. V. Sustainability of blood services. Bulletin of the National Research Institute of Public Health named after N. A. Semashko. 2017;(7):17—24 (In Russ.).</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Shevchenko Yu. L., Karpov O. E., Zhiburt E. B. Blood transfusion: history and modernity (on the 100th anniversary of blood transfusion in Russia). Bulletin of the Pirogov National Medical and Surgical Center. 2019;14(4):4—11 (In Russ.). DOI: 10.25881/BPNMSC.2020.29.78.001</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Zhiburt E. B., Shestakov E. A., Kuznetsov S. I. Hemolytic transfusion reactions. Bulletin of the Pirogov National Medical and Surgical Center. 2019;14(4):105—111 (In Russ.). DOI: 10.25881/BPNMSC.2020.17.22.020</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Zolotarev P. N., Cherkasov S. N. The market of medical laboratory services in the Russian Federation. Bulletin of the National Research Institute of Public Health named after N. A. Semashko. 2018;(4):14—18 (In Russ.). DOI: 10.25742/NRIPH.2018.04.011</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Zhiburt E. B. Transfusiological dictionary. Moscow: RAEN; 2012 (In Russ.).</mixed-citation></ref></ref-list></back></article>
